Document Detail


Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.
MedLine Citation:
PMID:  19217918     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study assessed the effects of the opioid antagonist naltrexone, the dopamine 2-like (D2) antagonist raclopride, and the GABA(B) agonist baclofen on consumption of fat/sucrose mixtures (FSM) using a limited access protocol. Sixty male Sprague-Dawley rats were grouped according to two schedules of access (Daily [D] or Intermittent [I]) to an optional FSM. Each FSM was created by whipping 3.2% (L), 10% (M), or 32% (H) powdered sugar into 100% vegetable shortening in a w/w manner (n=10 per group). One-hour intakes of the IL and IM groups were significantly greater than intakes of the respective DL and DM groups, thus fulfilling our operational definition of binge-type eating in these groups. Baclofen reduced intakes of the L and M mixtures regardless of access schedule, but failed to reduce intake of the H mixture. Naltrexone reduced intake in all groups, but potency was greater in IL rats than in DL rats. Furthermore, potency was attenuated in Intermittent rats, but enhanced in Daily rats, at higher sucrose concentrations. Raclopride reduced intake in the DL and stimulated intake in the IL groups, reduced intake in both M groups, and was without effect in both H groups. These results indicate that fat/sucrose mixtures containing relatively low concentrations of sucrose allow distinctions to be made between: 1) intakes stimulated by different access schedules and 2) opioid and dopaminergic modulation of those intakes. These results also suggest that brief bouts of food consumption involving fatty, sugar-rich foods may prove to be particularly resistant to pharmacological intervention.
Authors:
K J Wong; F H W Wojnicki; R L W Corwin
Related Documents :
6447118 - The three thiamin requirements of the rat.
20969838 - Olfactory bulbectomy impairs the feeding response to 2-deoxy-d-glucose in rats.
19043208 - Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic wistar ...
8945948 - Hyperinsulinemia in rats with obesity-inducing amygdaloid lesions.
17995868 - Color quality of oregon strawberries--impact of genotype, composition, and processing.
12777498 - Genetic and biochemical characterization of prta, an rtx-like metalloprotease from phot...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-02-13
Journal Detail:
Title:  Pharmacology, biochemistry, and behavior     Volume:  92     ISSN:  1873-5177     ISO Abbreviation:  Pharmacol. Biochem. Behav.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-03-23     Completed Date:  2009-08-05     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  0367050     Medline TA:  Pharmacol Biochem Behav     Country:  United States    
Other Details:
Languages:  eng     Pagination:  528-36     Citation Subset:  IM    
Affiliation:
The Pennsylvania State University, Nutritional Sciences Dept., 110 Chandlee Laboratory, University Park, PA 16802, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Baclofen / pharmacology*
Dietary Fats / administration & dosage*
Dietary Sucrose / administration & dosage*
Dopamine Antagonists / pharmacology
Feeding Behavior / drug effects
GABA Agonists / pharmacology
Male
Naltrexone / pharmacology*
Raclopride / pharmacology*
Rats
Rats, Sprague-Dawley
Grant Support
ID/Acronym/Agency:
1-R01-MH67943/MH/NIMH NIH HHS; R01 MH067943-04/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Dietary Fats; 0/Dietary Sucrose; 0/Dopamine Antagonists; 0/GABA Agonists; 1134-47-0/Baclofen; 16590-41-3/Naltrexone; 84225-95-6/Raclopride
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caffeine alters proliferation of neuronal precursors in the adult hippocampus.
Next Document:  Intracellular signaling pathways involved in inhibition of PAI-1 expression by CNP in endothelial ce...